Visceral leishmaniasis in Israel, 1960-2000

Israel Medical Association Journal

Volumn 6, Issue 4, 2004, Pages 205-208

  Ya'ari, Arnon ^a,c   Jaffe, Charles L ^b   Garty, Ben Zion ^a,c  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Leishmaniasis human immunodeficiency virus co infection; Visceral leishmaniasis

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; AWARENESS; CHILD; CLINICAL FEATURE; COMORBIDITY; ENDEMIC DISEASE; FEMALE; FEVER; GEOGRAPHIC DISTRIBUTION; HEPATOSPLENOMEGALY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; INCIDENCE; INFECTION CONTROL; ISRAEL; MALE; MEDICAL DOCUMENTATION; MEDICAL RECORD; PANCYTOPENIA; PARASITE VECTOR; SCIENTIFIC LITERATURE; VISCERAL LEISHMANIASIS; WEIGHT REDUCTION; ANIMAL; DISEASE CARRIER; DISEASE TRANSMISSION; PRESCHOOL CHILD;

ADULT; ANIMALS; CHILD, PRESCHOOL; DISEASE VECTORS; HUMANS; INCIDENCE; ISRAEL; LEISHMANIASIS, VISCERAL; MALE;

EID: 2342629898     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Berman JD. Human leishmaniasis: clinical diagnostic and chemotherapeutic development in the last 10 years. Clin Infect Dis 1997;24:684-703.
2. Western Galilee: Epidemiological review of the years 1960-1969. Harefauh 1972;83:223-5 (Hebrew).
3. Baneth G, Dank G, Keren-Kornblatt E, et al. Emergence of visceral leishmaniasis in central Israel. Am J Trop Med Hyg 1998;59:722-5.
4. Fabrikant T. A case of kala-azar originates in Palestine. Harefauh 1930;4:5-13 (Hebrew).
5. Adini I, Ephros M, Chen J, Jaffe CL. Asymptomatic visceral leishmaniasis, northern Israel. Emerg Infect Dis 2003;9:397-9.
6. Abdeen ZA, Sawalha SS, Eisenbergery CL, et al. Epidemiology of visceral leishmaniasis in the Jenin District, West Bank: 1989-1998. Am J Trop Med Hyg 2002;66:329-33.
7. Siegman-Igra Y, Waizband E, Rubinstein A, Shabi J, Cabili S. Visceral leishmaniasis presenting as fever of unknown origin. Trop Geogr Med 1987;39:70-2.
8. Marom D, Offer I, Tamary H, Garty BZ. Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis. Pediatr Hematol Oncol 2001;18:1-6.
9. Herwaldt BL. Leishamaniasis. Lancet 1999;354:1191-9.
10. World Health Organization. Global health situation: IV. Selected infectious and parasitic diseases due to idetified organisms. Wkly Epidemiol Rec 1993;6:41-8.
11. Shimshony A. Epidemiology of emerging zoonoses in Israel. Emgerging infectious disease. Presented at 1st International Conference on Emerging Zoonoses, Jerusalem, Israel. 1997;3:229-38.
12. David D, Rupprecht CE, Smith J, Samina I, Perl S, Stream Y. Human rabies in Israel. Emerg Infect Dis 1999;5:306-8.
13. Bettini S, Gradoni L. Canine leismaniasis in the Mediterranean and its implications for human leishmaniasis. Insect Sci Applic 1986;7:241-5.
14. Jaffe CL, Keren E, Nahary O, Rachamim N, Schnur L. Canine visceral leishmaniasis at Wadi Hamam, in Israel. Trans R Soc Trop Med Hyg 1988;82:852-3.
15. Ephros M, Paz A, Jaffe CL. Asymptomatic visceral leishmaniasis in Israel. Trans R Soc Trop Med Hyg 1994;88:651-2.
16. World Health Organization. Division of Control of Tropical Disease and UNAIDS. Leishmania and HIV: in gridlock. Geneva 1998; WHO/CTD/LEISH/98.9,UNAIDS/93.23 Add.I.
17. Ozbel Y, Turgay N, Ozensoy S, et al. Epidemiology, diagnosis and control leishmaniasis in the Mediterranean region. Ann Trop Med Parasitol 1995;89(Suppl 1):89-93.
18. Adini I, Ephos M, Chen J. Jaffe CL. Asymptomatic visceral leishmaniasis in Northern Israel. Emerg Infect Dis 2003;9:397-8.
19. Roger P, Fernando L, Bonaventura C. Leishmaniasis in HIV-infected persons. A review. IAPAC online 1997; http://www.iapac.org.clinmgt/coindisease/leishmaniasis.html.
20. World Health Organization. Leishmaniasis and leishmania/HIV co-infection. WHO Report on Global Surveillance of Epidemic-prone Infectious Disease. 2000; Chapter 10, and Fact Sheet No. 116, revised May 2000.
21. Murray HW, Rubin BY, Masur H, Roberts RB. Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med 1984;310:883-9.
22. Cascio A, Calattini S, Colomba C, et al. Polymerase chain reaction in the diagnosis and prognosis of Mediterranen visceral leishmaniasis in immunocompetent children. Pediatrics 2002;109(2):E27.
23. Montalban C, Calleja JL, Erice A, et al. Visceral leishmaniasis in patients infected with human immunodeficiency virus. J Infect 1990;21:261-70.
24. World Health Organization - Epidemiological Facts Sheets on HIV/AIDS and sexually transmitted infections. 2000 update (revised) - Israel. http://www/who/int/emc~hiv/fact_sheets/pdfs/Israel_EN/pdf.
25. Alexander J. Sex differences and cross immunity in DBA/2 mice infected with Leishmania mexicana and L. major. Parasitology 1988;96:297.